直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Federal Circuit IP Decisions

Appeal

Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.

Precedential

View Finnegan analysis

Case

18-1221

Venue
Federal Circuit
Decision Type
Affirmed in Part, Reversed in Part
Judges
Prost, Sharon; Alan Lourie; Evan Wallach; Authored by Lourie; Dissenting-in-part authored by Prost
Date
August 15, 2019

Originating Venue Decision

Orexigen Therapeutics, Inc. v. Actavis Laboratories FL, Inc.

Case

1:15-cv-00451

Venue
U.S. District Court, D. Delaware
Decision Type
Claim Construction Order
Judges
Richard Andrews
Date
June 10, 2016

Originating Venue Decision

Orexigen Therapeutics, Inc. v. Actavis Laboratories FL, Inc.

Case

1:15-cv-00451

Venue
U.S. District Court, D. Delaware
Decision Type
Memorandum Opinion, Order on Admissibility
Judges
Richard Andrews
Date
May 19, 2017

Originating Venue Decision

Orexigen Therapeutics, Inc. v. Actavis Laboratories FL, Inc.

Case

1:15-cv-00451

Venue
U.S. District Court, D. Delaware
Decision Type
Memorandum Opinion, Order on Admissibility
Judges
Richard Andrews
Date
May 31, 2017

Originating Venue Decision

Orexigen Therapeutics, Inc. v. Actavis Laboratories FL, Inc.

Case

1:15-cv-00451

Venue
U.S. District Court, D. Delaware
Decision Type
Memorandum Opinion, Not Invalid, Infringed
Judges
Richard Andrews
Date
October 13, 2017

Originating Venue Decision

Orexigen Therapeutics, Inc. v. Actavis Laboratories FL, Inc.

Case

1:15-cv-00451

Venue
U.S. District Court, D. Delaware
Decision Type
Final Judgment, Not Invalid, Infringed, Enjoined
Judges
Richard Andrews
Date
October 26, 2017

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP